India

Clinical trials in India are on the rise, there is a growing patient population, reliable assistance from the Indian government, and expanding technical structures within India. Experts believe that by 2011, 15% of the world’s clinical trials will be conducted in India.

PAREXEL has a strong presence, and has successfully supported numerous clinical studies in India. We are able to provide our customers with a wide array of quality clinical research services, because of our proven expertise. We are capable of covering an entire spectrum of product development stages from Phase I through to commercialization. PAREXEL has an extensive Investigator database, and we offer our clients an established patient recruitment focus, which covers many different therapeutic areas.

We are equipped to operate Data Management services globally and our World Wide Data Management team in India conducts vigorous analysis to determine the safety and efficacy of investigational products in order to gain regulatory approval and local market acceptance.
By conducting your clinical trial in India, you could benefit from the following advantages: 

  • Minimal time to get a drug to market
  • Sponsors will have a high patient recruitment and retention rate resulting in cost savings for the study
  • Incentives for free health care
  • Genetic diversity
  • “Rich World” illnesses such as; oncology, diabetes, cardiology infectious disease and respiratory disease
  • Alignment with GCP and ICH standards of conducting clinical trials in humans
  • English language is the primary language used for data collection and storage
  • Clinical data in India recognized by the FDA and other regulatory agencies for the purpose of regulatory submission

PAREXEL has multiple offices throughout India. Our local experts with specialized knowledge are committed to the success of your trial.  Click here to view India locations.